Rho-like GTPases orchestrate distinct cytoskeletal changes in response to receptor stimulation. Invasion of T-lymphoma cells into a fibroblast monolayer is induced by Tiam1, an activator of the Rho-like GTPase Rac, and by constitutively active V12Rac1. Here we show that activated V12Cdc42 can also induce invasion of T-lymphoma cells. Activated RhoA potentiates invasion, but fails by itself to mimic Rac and Cdc42. However, invasion is inhibited by the Rho-inactivating C3 transferase. Thus, RhoA is required but not sufficient for invasion. Invasion of T-lymphoma cells is critically dependent on the presence of serum. Serum can be replaced by the serum-borne lipids lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) (10 -7 -10 -6 M), which act on distinct G protein-linked receptors to activate RhoA and phospholipase C (PLC)-Ca 2ϩ signaling. LPA-and S1P-induced invasion is preceded by Rho-dependent F-actin redistribution and pseudopodia formation. However, expression of both V14RhoA and V12Rac1 does not bypass the LPA/S1P requirement for invasion, indicating involvement of an additional signaling pathway independent of RhoA. The PLC inhibitor U-73122, but not the inactive analog U-73343, abolishes invasion. Our results indicate that T-lymphoma invasion is driven by Tiam1/Rac or Cdc42 activation, and is dependent on LPA/S1P receptormediated RhoA and PLC signaling pathways which lead to pseudopod formation and enhanced infiltration.
Introduction
Rho-like GTPases, including RhoA, Rac1 and Cdc42, have been implicated in the control of a wide range of biological processes, such as the regulation of cytoskeletal structures, adhesion, motility, transcriptional activation and cell cycle progression (Van Aelst and D'SouzaSchorey, 1997; Hall, 1998) . Each of the Rho-like GTPases regulates distinct actin cytoskeletal rearrangements in response to receptor stimulation. In fibroblasts, Cdc42 controls the formation of microspikes (Kozma et al., 1995; Nobes and Hall, 1995) , whereas Rac regulates the formation of lamellipodia and membrane ruffles . Activation of RhoA leads to the induction of stress fibers . Moreover, all three GTPases induce the formation of integrin adhesion complexes in Swiss 3T3 fibroblasts (Hall, 1998) , and stimulate transcriptional activation and DNA replication (Olson et al., 1995; Vojtek and Cooper, 1995; Perona et al., 1997) .
In search of genes involved in the process of tumor cell invasion and metastasis, we previously have identified the Tiam1 gene by retroviral insertional mutagenesis in combination with in vitro selection of invasive Tlymphoma variants (Habets et al., 1994) . The Tiam1 protein consists of 1591 amino acids and contains several conserved protein motifs, including a Dbl homology (DH) domain. The DH domain is the catalytic domain in many guanine nucleotide exchange factors (GEFs), which activate members of the Rho subfamily of small GTPases (Collard, 1996; Whitehead et al., 1997) . GEFs promote the exchange of bound GDP for GTP on these GTPases, which results in their activation. Whereas Tiam1 displays GEF activity towards all three Rho-like GTPases Rac1, Cdc42 and RhoA in vitro, Tiam1 specifically activates Rac in vivo (Michiels et al., 1995) . In fibroblasts, Tiam1 induces the formation of membrane ruffles and stimulates the activation of the Jun N-terminal kinase (JNK), similarly to activated V12Rac1 . Furthermore, V12Rac1 induces invasion of T-lymphoma cells, suggesting that Tiam1-induced invasiveness of T-lymphoma cells is caused by activation of Rac (Michiels et al., 1995) .
Rac1 regulates the organization of the cortical actin cytoskeleton, and in fibroblasts it induces the formation of lamellipodia and membrane ruffling, which are believed to play an important role in cell motility (Stossel, 1993) . The role of RhoA in cell adhesion and motility has been studied extensively by using C3 transferase, a toxin that specifically inhibits Rho activity (Sekine et al., 1989) . Lysophosphatidic acid (LPA), a serum-borne lipid mitogen (Eichholtz et al., 1993) , activates its cognate G protein receptor to stimulate multiple signaling pathways including RhoA signaling (Moolenaar et al., 1997) . LPA induces RhoA-dependent stress fiber formation in fibroblasts as well as neurite retraction in neuroblastoma cells (Jalink et al., 1994) . Both processes are inhibited by C3 transferase. A related platelet-derived serum lysophospholipid, sphingosine-1-phosphate (S1P), has been implicated in the control of cell proliferation, invasion and apoptosis (Cuvillier et al., 1996; Spiegel and Merrill, 1996; Yatomi et al., 1997) . Like LPA, S1P activates its own G protein-coupled receptor (Bunemann et al., 1996; Okajima et al., 1996; Postma et al., 1996; Meyer zu Heringdorf et al., 1997; Zondag et al., 1998) , although S1P has also been proposed to have an intracellular messenger function (Spiegel and Merrill, 1996) . In N1E-115 neuroblastoma cells, LPA and S1P activate their respective receptors to trigger RhoA-dependent neurite retraction (Jalink et al., 1994; Postma et al., 1996) . Furthermore, LPA induces RhoA-dependent invasion of hepatoma cells (Imamura et al., 1993; Yoshioka et al., 1995) , while invasiveness of T-cell hybrids also depends on RhoA (Verschueren et al., 1997) . In contrast, S1P exerts inhibitory effects on the motility of smooth muscle and melanoma cells (Sadahira et al., 1992; Bornfeldt et al., 1995 , Yamamura et al., 1997 .
In this study, we have investigated the role of Cdc42, Rac1 and RhoA in T-lymphoma invasion into a fibroblast monolayer and explored the nature of the serum components required for invasion. Our results indicate that Tlymphoma invasion is driven by Tiam1/Rac or Cdc42 activation. We find that LPA and S1P can fully replace serum in promoting T-lymphoma invasion. Invasion appears to depend on LPA/S1P receptor-mediated RhoA and phospholipase C (PLC) signaling pathways, leading to pseudopod formation and subsequent infiltration into fibroblast monolayers.
Results

Constitutively active V12Cdc42 induces invasion of T-lymphoma cells similarly to V12Rac1
Previously, we have shown that constitutively active V12Rac1 induces invasiveness of T-lymphoma cells (Michiels et al., 1995) . To determine the effect of Cdc42 on invasion of T-lymphoma cells, we introduced constitutively active V12Cdc42 into non-invasive BW5147 cells by retroviral transduction. Pools of transduced cells were subjected to three rounds of invasion selection (see Materials and methods). The invasive cells thus selected highly expressed V12Cdc42 ( Figure 1A, lanes 1 and 2) . Control cells transduced with the empty vector or a vector encoding V14RhoA did not become invasive, as shown previously (Michiels et al., 1995) . The efficiency of invasion was assayed by layering the lymphoma cells on a monolayer of rat embryo fibroblasts (REFs) for 4 h, after which non-invaded cells were washed away ( Figure  1B ). Similar to V12Rac1-transduced cells (Michiels et al, 1995) , 10-20% of selected V12Cdc42-expressing cells infiltrated within 4 h into the fibroblast monolayer. The infiltrated cells showed high levels of V12Cdc42 expression, but rapidly lost expression as well as invasive capacity after propagation, due to V12Cdc42-induced polyploidization and growth arrest. From these studies, we conclude that similarly to V12Rac, overexpression of V12Cdc42 leads to an invasive phenotype in T-lymphoma cells. Since V12Cdc42-expressing cells were less stable than V12Rac1-expressing cells, they were not included in further studies.
RhoA activity is required but not sufficient for Tiam1-and Rac1-induced invasion Although expression of V14RhoA was not sufficient to induce invasiveness, endogenous RhoA could still be involved in T-lymphoma invasion. To test this, Tlymphoma cells, which had acquired invasiveness either by proviral insertion in the Tiam1 gene (Habets et al., 1994) or by expression of exogenous V12Rac1 (Michiels et al., 1995) , were pre-incubated with C3 transferase for 24 h. C3 transferase inactivates RhoA by ADP ribosylation in its putative effector domain (Sekine et al., 1989) . As shown in Figure 2 , pre-treatment of the cells by C3 transferase resulted in an inhibition of invasive capacity for all invasive cell lines tested. This indicates that invasion Figure 2) were tested for invasive capacity in medium containing 10% FCS, in serumfree medium, and in serum-free medium containing 5 μM LPA. Data are presented as mean Ϯ SEM. (B) Dose-response relationship of LPA-and S1P-stimulated invasion. The invasive capacity of the cell line BW MLV2.9 was tested in serum-free medium with BSA and the indicated concentrations of LPA and S1P. Other cell lines showed similar responses. of these T-lymphoma cells requires not only an activated Tiam1/Rac signaling pathway, but also RhoA activity.
Serum is required for invasion and can be substituted for by LPA and S1P T-lymphoma invasion was critically dependent on the presence of serum ( Figure 3A ): in serum-containing media, 15-25% of the various T-lymphoma variant cells invaded into the fibroblast monolayer within 4 h. Hardly any invasion occurred under serum-free conditions. Since LPA is a serum factor known to activate RhoA, whilst Tlymphoma invasion is RhoA-dependent, we tested whether LPA could substitute for serum. Indeed, we found that LPA can completely replace the serum requirement during invasion ( Figure 3A ). LPA (5 μM) promoted invasion more efficiently than serum (10%). Other receptor ligands such as bombesin (10 nM), platelet-derived growth factor (PDGF; 30 ng/ml), epidermal growth factor (EGF; 100 ng/ml), bradykinin (10 ng/ml) or insulin (1 μg/ml) had no effect on invasion (not shown). These results suggest that LPA is the active serum ingredient responsible for invasion. Another serum-borne lysolipid, S1P , reproduces many effects of LPA but acts on a distinct receptor (Postma et al., 1996; Meyer zu Heringdorf et al., 1997) . S1P acted similarly to LPA and stimulated T-lymphoma invasion under serum-free conditions. The stimulation of invasion by S1P and LPA was dosedependent, with LPA having an EC 50 of 2 μM, with maximal invasion being reached at 5 μM. S1P stimulated invasion with an EC 50 of~350 nM and maximal invasion at~1 μM ( Figure 3B ). Other related lipids such as sphingosyl-phosphorylcholine, phosphatidic acid and cellpermeable C8-ceramide had no effect (Table I) . Suramin (1 mg/ml), a known inhibitor of the interaction between LPA/S1P and their respective receptors (Jalink et al., 1995; Postma et al., 1996) , abolished the stimulation of invasion by both LPA and S1P (Table I) . Furthermore, both LPA and S1P evoke a transient Ca 2ϩ signal in Tlymphoma cells (see below; Figure 6 ), indicating the presence of functional LPA/S1P receptors on the lymphoma cell surface. From these results, we conclude (Table I) . Bar represents 25 μm.
that LPA and S1P stimulate invasion of T-lymphoma cells through activation of their cognate G protein-coupled receptors.
Effects of LPA and S1P on the actin cytoskeleton In fibroblasts and neuroblastoma cells, LPA and S1P induce rapid RhoA-mediated rearrangements of the actin cytoskeleton. We investigated cytoskeletal rearrangements in T-lymphoma cells treated with LPA or S1P. Figure 4A and D shows that T-lymphoma cells are rounded under serum-free conditions. Addition of LPA (5 μM) or S1P (1 μM) induced marked morphological changes within 20-60 min, notably a transition from a rounded to a pluriform shape with extending pseudopodia ( Figure 4B , C and E). This response was observed consistently in all T-lymphoma cell lines tested. Fluorescence staining of F-actin showed that a layer of cortical actin is present underneath the plasma membrane. Following LPA or S1P treatment, F-actin relocalized to the sites of newly formed pseudopodia ( Figure 4D and E). Cytochalasin B (CCB; 1 μM) abolished the morphological responses to LPA and 4069 S1P ( Figure 4K ) as well as invasion ( Table I ), confirming that these events require an intact actin cytoskeleton.
RhoA stimulates myosin light chain (MLC) phosphorylation leading to enhanced actomyosin contractility (Chrzanowska-Wodnicka and Burridge, 1996; Kimura et al., 1996) . Both the Rho-inactivating C3 transferase (30 μg/ml) and the myosin light chain kinase (MLCK) inhibitor KT5926 (5 μM) blocked the induction of pseudopods by LPA ( Figure 4J and H) and inhibited invasion (Table I) . This supports the notion that RhoA regulation of actomyosin contractility is required for invasion. Thus, in addition to forming stress fibers in fibroblasts and triggering neurite retraction in neuroblastoma cells, LPA and S1P induce actin-mediated pseudopodal extensions in T-lymphoma cells.
Constitutively active RhoA enhances invasion induced by activated Rac1, but invasion is still largely dependent on serum Since LPA and S1P activate RhoA, we reasoned that V14RhoA might bypass the LPA/S1P (or serum) dependence of invasion. To test this notion, we generated invasive T-lymphoma cells expressing both V12Rac1 and V14RhoA. Using retroviral transduction, V14RhoA was introduced into invasive V12Rac1-transduced (BWRac) cells and V12Rac1 was introduced into non-invasive V14RhoA-transduced (BWRho) cells. The BWRacRho bulk populations, obtained by both methods, were also subjected to single cell cloning in order to prevent selective loss of putative serum-independent, but perhaps more slowly growing invasive clones. Figure 5A shows the expression levels of V12Rac1 and V14RhoA in BWRac-, BWRho-and BWRacRho-transduced cells, as determined by Western blot analysis. Expression levels of V14RhoA in BWRacRho bulk populations and subclones were variable, whereas V12Rac1 levels (detected through the same Myctag) were relatively high in all invasive cell lines ( Figure  5A, lanes 3-9) .
Transduction of V14RhoA into the already invasive V12Rac1-expressing cells increased the invasive potential of these cells. High expression levels of V14RhoA in the BWRacRho cell lines correlated with increased invasive capacity in the presence of serum ( Figure 5B ). These cells also showed some increased invasive capacity (up to 7%) in the absence of serum, suggesting that V14RhoA can bypass the serum requirement to a limited extent. However, invasion of BWRacRho cells still appeared to be largely dependent on serum ( Figure 5B ). Similar results were obtained when serum was replaced by either LPA or S1P. From these results, we conclude that LPA-and S1P-induced invasion depends on both RhoA-dependent and RhoA-independent signaling pathways.
Possible involvement of PLC
To gain insight into the RhoA-independent signaling pathway(s) required for invasion of T-lymphoma cells, we analyzed the involvement of known effectors that are activated by LPA and S1P. In fibroblasts, the LPA receptor couples to G proteins of the G i , G q and G 12/13 subclass (Moolenaar et al., 1997) . G i mediates activation of the mitogenic Ras/MAPK pathway and inhibition of adenylate cyclase. G 12/13 couples to RhoA activation, whilst G q activates phospholipase C-β (PLCβ). Pre-treatment of the cells with pertussis toxin (PT), which inactivates G i , did not inhibit invasion of the BWRac and BWMLV cells (Table I) , ruling out a critical role for G i . Unlike the situation in fibroblasts, addition of LPA (2-10 min) to serum-deprived T-lymphoma cells (BWRac and BW5147) induced only a slight increase in phosphorylation of ERK, which was inhibited by the MEKK inhibitor PD98059 at 5 μM concentration (not shown). However, at this concentration, PD98059 did not inhibit LPA-induced invasion (Table I) or pseudopod formation ( Figure 4L ). These results argue against a role for the G i -Ras-ERK pathway in LPA-induced invasion of T-lymphoma cells.
LPA and S1P receptors also couple to activation of PLC and PLD (Desai et al., 1992; Van der Bend et al., 1992; Cross et al., 1996; Okajima et al., 1996) . PLC stimulation results in the generation of diacylglycerol (DAG) and inositol 1,4,5-trisphosphate which activate protein kinase C (PKC) and mobilize Ca 2ϩ , respectively. Addition of LPA to T-lymphoma cells evoked a rapid but transient rise in intracellular Ca 2ϩ (Figure 6 ), indicative of PLC activation. Due to homologous desensitization, a second addition of LPA was ineffective; however, it did not interfere with a subsequent S1P-induced Ca 2ϩ transient ( Figure 6 ). This indicates that LPA and S1P activate distinct Ca 2ϩ -mobilizing receptors in T-lymphoma cells.
The PLC inhibitor U-73122 (1 μM) inhibited invasion by Ͼ90%, whereas the inactive congener U-73343 had no effect (Table I) . Furthermore, addition of butan-1-ol, to prevent PLD-induced formation of phosphatidic acid (PA), did not affect invasion (Table I) . These results suggest a role for PLC, but not PLD, in LPA/S1P-induced invasion. Inhibition of PLC by U-73343 also inhibited induction of shape changes by LPA ( Figure 4F and I). Phase-contrast microscopy showed cells with an uneven, rough surface ( Figure 4I ), and the cortical F-actin layer seemed more fragmented than in control cells ( Figure 4D and F). These results suggest that LPA/S1P-induced PLC activation is required for both invasion and pseudopodia formation.
To gain insight into the PLC-directed downstream pathways involved in invasion, we pre-treated invasive cells with phorbol 12-myristate 13-acetate (PMA) for 24 h to downregulate the level of classical PKC isoforms. Downregulation of PKC by PMA or treatment of cells with the PKC inhibitor Ro-31-8220, had no substantial effect on invasion (Table I) . Moreover, short pre-treatment of BWRacRho cells with PMA to activate PKC did not mimic the LPA effect in the absence of serum (Table I) . PMA-treated cells did not produce pseudopodia and did not acquire invasive capacity, making it unlikely that PLCinduced DAG-mediated PKC activation plays an important role in LPA-induced invasion. To test whether Ca 2ϩ -mobilization could be involved, ionomycin and thapsigargin were used to raise the intracellular Ca 2ϩ concentration in BWRacRho cells. Different concentrations of ionomycin and thapsigargin, which were shown to induce adhesion of T-lymphoblastoid cells (Stewart et al., 1998) , did not induce the formation of pseudopods and resulted in only a slight increase in invasion of BWRacRho cells in the absence of serum (Table I) . However, binding of intracellular Ca 2ϩ by the Ca 2ϩ chelator BAPTA-AM (20 μM) inhibited invasion by Ͼ60% (Table I) , as well as the formation of pseudopodia (not shown). Apparently, Ca 2ϩ is required for invasion, but increasing intracellular Ca 2ϩ is not sufficient to induce invasion. Precisely how LPA-and S1P-induced PLC activation may contribute to T-lymphoma invasion awaits further studies.
Discussion
We have shown previously that the Rac-specific exchange factor Tiam1 and constitutively active V12Rac1 render T-lymphoma cells invasive (Habets et al., 1994; Michiels et al., 1995) . In this study, we show that activated V12Cdc42 also induces invasiveness, albeit somewhat less efficiently than V12Rac1. Furthermore, we show that invasion requires serum and that serum can be functionally replaced by the lysolipids LPA or S1P acting on their respective G protein-coupled receptors.
In epithelial cells, both V12Rac1 and V12Cdc42 are able to promote motility and invasion when homotypic Ecadherin-mediated adhesion is prevented Keely et al., 1997) . Cdc42 was shown to activate Rac in various cell types (Nobes and Hall, 1995; Van Leeuwen et al., 1997) , whilst Cdc42 and Rac share several downstream effectors (Hall, 1998 ) that may play a role in the induction of invasion. We show here that V14RhoA potentiates Rac/Cdc42-induced invasion but is unable by itself to substitute for Rac or Cdc42. These findings, together with those obtained with C3 transferase, indicate that RhoA activity is required but not sufficient for invasion. Although LPA and S1P activate RhoA, Tlymphoma cells expressing both V14RhoA and V12Rac1 displayed enhanced invasiveness but still required LPA or S1P for efficient invasion. We conclude, therefore, that LPA or S1P stimulate an additional RhoA-independent signaling pathway that is required for invasion.
LPA and S1P stimulate invasion LPA and S1P activate their own G protein-coupled receptor (Guo et al., 1996; Postma et al., 1996) . The receptor antagonist suramin abolished the stimulation of invasion by both LPA and S1P, while LPA and S1P evoke a rise in intracellular Ca 2ϩ that is not subject to crossdesensitization. Thus, both LPA and S1P act through their respective receptors on the T-lymphoma cell surface.
Both LPA and S1P induce RhoA-dependent stress fiber formation in fibroblasts, and neurite retraction in neuronal cells (Postma et al., 1996; Van Leeuwen, et al., 1997; Wang et al., 1997) . LPA also stimulates RhoA-dependent invasion of hepatoma cells (Imamura et al., 1993; Yoshioka et al., 1995) . Consistent with these results, we observed that both LPA and S1P stimulate RhoA-dependent invasion of T-lymphoma cells. This is in contrast to the reported inhibition by S1P of motility and chemotaxis of smooth muscle cells and melanoma cells (Sadahira et al., 1992; Bornfeldt et al., 1995) . Inhibition of invasion of these cell types, as assayed in a Boyden chamber, correlated with a reduction in actin polymerization and formation of focal adhesions. This cell type-dependent discrepancy in S1P effects on tumor cell invasion is intriguing and deserves further investigation.
Possible PLC involvement in invasion
In fibroblasts, LPA activates various signaling pathways, including the G i -Ras-ERK pathway and stimulation of RhoA, PLC and PLD (Moolenaar et al., 1997) . PT and the MEKK inhibitor PD98059 failed to inhibit invasion, which argues against a role for Ras-ERK signaling. The PLC inhibitor U-73122 abolished invasion of all T-lymphoma cell lines tested, including cells expressing both V12Rac and V14RhoA. Some caution is needed, however, since the U-73122 compound might have illdefined side effects that are unrelated to PLC inhibition. PLC stimulation generates DAG and inositol 1,4,5-tris-phosphate, which activate PKC and mobilize Ca 2ϩ from intracellular stores, respectively. PKC recently has been shown to phosphorylate Tiam1 (Fleming et al., 1997) . However, PKC activation by PMA did not induce invasion of BWRacRho cells in the absence of serum or LPA. Moreover, inactivation of PKC by long-term treatment with PMA or by Ro-31-8220 treatment did not affect invasion of Tiam1-transduced cells, suggesting that PKC activation is not required for PLC-mediated invasion of T-lymphoma cells. LPA and S1P induce Ca 2ϩ mobilization in the T-lymphoma cells through activation of distinct cell surface receptors, as is observed in other cell types (Guo et al., 1996; Postma et al., 1996) . LPA and S1P activate RhoA, but cells expressing both V12Rac and V14RhoA still needed either of these lipids for strong invasion. These results indicate that activation of PLC by LPA or S1P is also required for invasion, independently of activation of RhoA. Whereas Ca 2ϩ is a well-known regulator of cytoskeletal organization, Ca 2ϩ mobilization by ionomycin or thapsigargin hardly induced invasion in serum-free conditions. However, the intracellular Ca 2ϩ -chelator BAPTA-AM inhibited LPA-induced formation of pseudopodia as well as invasion, indicating that Ca 2ϩ is required but Ca 2ϩ mobilization is not sufficient for invasion. As was shown recently (Stewart et al., 1998) , Ca 2ϩ might play a role in integrin-mediated adhesion, a prerequisite for invasion, but also seems to be involved in LPAinduced formation of pseudopodia. Rho-like GTPases and PLC-regulated phosphoinositide metabolism may also interact during invasion. Phosphoinositides have been implicated in the regulation of the actin cytoskeleton, for example by binding to actin-capping proteins (Hartwig and Barkalow, 1997; Toker and Cantley, 1997) , and in intracellular targeting of signaling molecules, including activators of Rho-like GTPases Toker and Cantley, 1997; Han et al., 1998; Nimnual et al., 1998) .
Invasion and the actomyosin cytoskeleton
Invasion requires cells to adhere, to form cell protrusions, to detach, to contract and to regulate cell rigidity in order to extravasate. All these processes require a strict regulation of the actomyosin cytoskeleton in which Rholike GTPases play an important role (Hall, 1998) . LPA and S1P induced shape changes of T-lymphoma cells, resulting in the formation of pseudopodia. The lipidinduced pseudopodia formation was also observed in cells expressing V14RhoA, indicating that activation of RhoA is not sufficient to induce this response. The cytoskeletal rearrangements did not occur after inactivation of RhoA by C3 transferase or after inhibition of MLCK by KT5926. Since RhoA couples to inhibition of MLC phosphatase (Kimura et al., 1996) , this suggests that the morphological changes induced by LPA or S1P require actomyosinmediated contractility regulated by RhoA, as well as a RhoA-independent PLC-mediated signaling pathway. The abolishment of shape changes and invasion by inhibitors of PLC, MLCK or RhoA underscores the importance of actin regulation for the invasion process. Although the cytoskeletal rearrangements induced by LPA or S1P are clearly important, they are not sufficient to achieve invasion. Shape changes and pseudopodia formation induced by both lipids also occurred in non-invasive control Fig. 7 . Signaling pathways involved in T-lymphoma invasion. Invasion is mediated by the combined activities of Rac (or Cdc42), RhoA and PLC. Tiam1 activates Rac. LPA and S1P activate receptors which couple to heterotrimeric G proteins which activate RhoA and PLC. RhoA activation, together with a RhoA-independent PLC-mediated pathway, leads to pseudopodia formation, whereas Rac and Cdc42 activation promote actin polymerization and adhesion. PLC-mediated Ca 2ϩ signaling and regulation of phosphatidylinositol lipids, which both are involved in cytoskeletal rearrangements, may play a role in pseudopodia formation. The coordinated activation of Cdc42, Rac, RhoA and PLC potentially regulates cell adhesion and local cytoskeletal rearrangements required for invasion. PT, pertussis toxin; C3, C3 transferase. The inhibitors that are framed abolish pseudopodia formation as well as invasion.
T-lymphoma cells. Based on these data, we propose that RhoA as well as a PLC-mediated pathway are required for the formation of pseudopodia, whereas Tiam1/Rac-or Cdc42-mediated pathways are necessary to allow adhesion and further cytoskeletal rearrangements (Figure 7) . In lymphoid cells, Cdc42 has been shown to induce cell polarization (Stowers et al., 1995) , and both Cdc42 and Rac promote adhesion and lamellipodia formation in different cell types (Machesky and Hall, 1997; Michiels et al., 1997; Van Leeuwen et al., 1997) . Actin cytoskeleton rearrangements as well as specific adhesion events will be required at different sites during the various stages of the invasion process. REF 208F cells were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% heat-inactivated newborn calf serum. All transduced cells were derived from the non-invasive BW5147 T-lymphoma cells and were grown in suspension in RPMI 1640 medium with 10% heatinactivated fetal calf serum (FCS). Cell lines BW MLV3.1, BW MLV3.2 and BW MLV4.13 represent invasive variants of BW5147 cells that carry a Moloney murine leukemia proviral insertion in the Tiam1 gene, resulting in high expression of truncated Tiam1 proteins (Habets et al., 1994) . BWRac cells express Myc-tagged V12Rac1 introduced by retroviral transduction (Michiels et al., 1995) .
Materials and methods
Cells and culture conditions
Materials
LPA (1-oleoyl and 1-palmitoyl), phosphatidic acid and CCB were obtained from Sigma. PT was from List Laboratories; butan-1-ol from Merck; PMA, Ro-31-8220, thapsigargin, ionomycin, BAPTA-AM, PD98059 and KT5926 from Calbiochem. S1P (98% pure), C8-ceramide, sphingosine phosphatidylcholine, PLC inhibitor 1-{6-[(17β-3-methoxestra-1,3,5(10)trien-17-yl)amino]hexyl}-1H-pyrrole-2,5-dione (U-73122) and its inactive congener 1-{6-[(17β-3-methoxestra-1,3,5(10)trien-17-yl)amino]hexyl}-2,5-pyrrolidine-dione (U-73343) were purchased from Biomol (Plymouth Meeting, PA). Suramin was obtained from Bayer
4072
(Germany) and indo-1 acetoxymethylester (indo-1 AM) from Molecular Probes. Recombinant C3 transferase was kindly provided by S.Narumiya (University of Kyoto, Japan). S1P stock solutions (2 mM) were made in methanol, LPA stock solution (10 mM) in H 2 O. U-73122 and U-73343 were dissolved in dimethylsulfoxide (DMSO; 5 mM).
Invasion assay
Invasion into REF monolayers was determined essentially as described (Habets et al., 1994) . REFs were grown to confluency in 24-well plates and washed twice with RPMI. A total of 7ϫ10 5 T-lymphoma cells were added in 1 ml. After incubation for 4 h, non-invaded cells were removed by washing and mechanical agitation (four times) in phosphate-buffered saline (PBS) containing 1 mM CaCl 2 and 1 mM MgCl 2 . The infiltrated cells were counted using a phase-contrast microscope, and the degree of invasion was expressed as the percentage of cells added. Less than 2% invasion was considered as background. Standard invasion assays were performed in RPMI containing 10% FCS, or RPMI with 0.5 mg/ml fatty acid-free bovine serum albumin (BSA, Sigma) to which LPA or S1P were added in various concentrations.
To determine the effects of inhibitors, 10 6 cells were pre-treated as follows: incubation in serum-free medium with 200 ng/ml PT for 2 h; in serum-containing medium with 1 μM U-73122 or U-73343 for 5 min; with 5 μM KT5926 for 10 min; with 1 μM CCB for 30 min; with 1 μM PMA for 24 h; with 5 μM Ro-31-8220 for 30 min; or with 30 μg/ml C3 transferase for 24 h. Subsequently, the cells were washed and assayed for invasive potential in serum-free medium in the presence of LPA. PD98059 (5 μM) was added in serum-free medium for 30 min prior to addition of LPA. Cells were pre-treated with BAPTA-AM (20 μM) for 10 min in PBS/20 μM EGTA, washed and BAPTA-AM (20 μM) was added again during the invasion assay. Other inhibitors and agonists were added to the indicated concentrations during the invasion assay. Viability of the cells was not affected, as determined by Trypan Blue exclusion.
Retroviral transduction
We previously described the cloning of Myc-tagged V12Rac1 in a pMFG plasmid, which was transfected into a BOSC23 packaging cell line to produce V12Rac1-transducing retroviruses (Michiels et al., 1995) . For the present study, Myc-tagged V14RhoA was cloned into a pMFG-IRES-LacZ retroviral vector (Staal et al., 1996) and transfected into the BOSC23 packaging cell line to produce V14RhoA-IRES-LacZtransducing retroviruses. Cells transduced with this construct express, in addition to V14RhoA, also the LacZ protein encoded on the same mRNA, since IRES represents an internal ribosomal entry site allowing translation of LacZ. Thus, X-gal staining is quantitatively correlated to V14RhoA expression, as was confirmed experimentally (not shown). V12Cdc42-expressing retroviral constructs will be described in detail elsewhere (F.Michiels, R.A.van der Kammen and J.G.Collard, in preparation).
BW5147 T-lymphoma cells (5ϫ10 5 ) were infected by culturing for 18 h in 2.5 ml of cell-free BOSC23 supernatants, in the presence of 6 μg/ml polybrene. Infection with V14RhoA-IRES-LacZ retrovirus yielded transductants that were selected by FACS sorting after viable staining for LacZ expression (Nolan et al., 1988) . Single cell clones were generated and analyzed by X-gal staining and Western blotting for V14RhoA (not shown). The single cell clone displaying the highest level of V14RhoA expression was employed as a BWRhoA cell line. To obtain BWRacRho cells, the BWRac line was transduced with V14RhoA-IRES-LacZ retrovirus or empty vector. After two cycles of FACS sorting, a bulk population of BWRacRho was obtained, as well as single cell clones. The empty vector yielded clones expressing only LacZ, in addition to V12Rac1, which did not affect invasive properties. Similarly, the BWRho cell line was also transduced with the V12Rac1 retrovirus. Successful transductants were selected by invasion selection on REFs (as in Michiels et al., 1995) and also single cell clones were generated.
Western blot analysis, immunofluorescence and CLSM analysis These were performed as described recently , using mouse monoclonal 9E10 antibodies to recognize the Myc epitopetagged Rac, Rho and Cdc42 proteins. For actin staining, tetramethylrhodamine isothiocyanate (TRITC)-labeled phalloidin was used.
Calcium measurements
T-lymphoma cells (10 7 ) were washed with RPMI (without serum) and loaded with indo-1 AM by incubation for 30 min in 1 ml of RPMI with 10 μM indo-1 AM at 37°C. The cells were washed with PBS containing 1 mM CaCl 2 and 1 mM MgCl 2 , incubated in quartz cuvettes (2ϫ10 6 cells/ml) and stimulated with LPA (5 μM) or S1P (1 μM), as indicated. Experiments were performed with a Perkin-Elmer LS3 spectrofluorometer, as described by Jalink et al. (1990) .
